HIGHFDA DRUG

Midodrine Hydrochloride Tablets Recall 8,892 Cartons Nationwide (2026)

Midodrine Hydrochloride Tablets, 5 mg, 50 tablets in 5 x 10 blister packs, distributed nationwide by Major Pharmaceuticals, are recalled. The packaging defect involves inadequately sealed blister packaging. Healthcare providers and patients should stop using the product immediately and contact The Harvard Drug Group LLC for guidance.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
February 17, 2026
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
February 17, 2026
Hazard Level
HIGH
Brand
Midodrine Hydrochloride
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Midodrine Hydrochloride
Product type
Midodrine Hydrochloride Tablets
Model numbers
Lot N02640
UPC codes
0904-6817, 0904-6818, 0904-6819, 0904-6817-06, 0904-6817-61, 0904-6818-06, 0904-6818-61, 0904-6819-07
Sold at
Unknown
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    February 17, 2026

  2. Reported by FDA DRUG

    March 11, 2026

  3. RecallRadar source check

    March 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Defective container; inadequately sealed blister packaging.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact The Harvard Drug Group LLC or your healthcare provider for guidance. Notification method: Letter

About This Product

Midodrine hydrochloride is a prescription medication used to treat orthostatic hypotension by increasing blood pressure. It is supplied in tablet form for oral administration.

Why This Is Dangerous

A defective blister packaging can compromise drug integrity and may lead to contamination or reduced potency if used.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

The recall affects 8,892 cartons nationwide. Healthcare providers and patients should stop using the product immediately and seek guidance from The Harvard Drug Group. No injuries or deaths are reported in the notice.

Practical Guidance

How to identify if yours is affected

  1. Check NDC 0904-6818-06 on the package
  2. Locate Lot N02640 on the blister or carton
  3. Verify Expiration Date 08/2027
  4. If all match, stop using the product and contact the Harvard Drug Group for guidance

Where to find product info

FDA recall page: https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0383-2026

What timeline to expect

Recall notice indicates disposition by letter from the Harvard Drug Group; exact refund/replacement timelines are not specified.

If the manufacturer is unresponsive

  • Document all communications with healthcare providers and the Harvard Drug Group
  • File a complaint with the FDA if the company is unresponsive
  • Consult your state pharmacy board for additional guidance

How to prevent similar issues

  • Verify NDC, lot number, and expiration date before dispensing any medication
  • Inspect packaging integrity on receipt of Rx drugs
  • Only use medications from approved and licensed pharmacies
  • When in doubt, contact a healthcare professional before use

Documentation advice

Keep recall notice, packaging, lot numbers, and all correspondence with the provider and distributor for records

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Product: Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs)\nNDC: 0904-6818-06\nLot: N02640\nExp: 08/2027\nRecall quantity: 8,892 cartons\nSold/distributed: Nationwide US\nDistributor/packager: Major Pharmaceuticals, Indianapolis, IN 46268 USA\nRecall date: 2026-02-17\nStatus: ACTIVE\nClassification: Class II

Key Facts

  • Distributed nationwide in the US
  • Defective blister packaging

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
Lot N02640
UPC Codes
0904-6817
0904-6818
0904-6819
+5 more
Affected States
ALL
Report Date
March 11, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

LACTATED RINGERS
Presence of
Read more